Literature DB >> 14316200

VINBLASTINE SULPHATE IN THE TREATMENT OF MALIGNANT DISEASE.

N M BLEEHEN, A M JELLIFFE.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; DRUG THERAPY; HODGKIN'S DISEASE; LYMPHOMA; NEOPLASM THERAPY; TOXICOLOGIC REPORT; VINBLASTINE

Mesh:

Substances:

Year:  1965        PMID: 14316200      PMCID: PMC2071368          DOI: 10.1038/bjc.1965.30

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  2 in total

1.  Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease.

Authors:  O H WARWICK; J M DARTE; T C BROWN; C T BEER; J H CUTTS; R L NOBLE
Journal:  Cancer Res       Date:  1960-08       Impact factor: 12.701

2.  Vincaleukoblastine. I. Preliminary clinical studies.

Authors:  M E HODES; R J ROHN; W H BOND
Journal:  Cancer Res       Date:  1960-08       Impact factor: 12.701

  2 in total
  9 in total

1.  Chemotherapy of Hodgkin's Disease with Cyclophosphamide, Vinblastine, and Procarbazine.

Authors:  G H Fairley; M J Patterson; R B Scott
Journal:  Br Med J       Date:  1966-07-09

2.  Phase II study of divided-dose vinblastine in advanced breast cancer patients.

Authors:  G Giaccone; M Bagatella; O Bertetto; M Donadio; A Calciati
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  The myenteric plexus in drug-induced neuropathy.

Authors:  B Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1967-12       Impact factor: 10.154

4.  Side-effects of vinca alkaloids.

Authors:  A Vlădutiu
Journal:  Br Med J       Date:  1968-06-22

5.  Side-effects of Vinca alkaloids.

Authors:  W G Bradley
Journal:  Br Med J       Date:  1968-07-06

6.  [Long term treatment of advanced lymphogranulomatosis with vinblastine sulfate].

Authors:  E Schulz; W Jüngling; K Hausmann
Journal:  Klin Wochenschr       Date:  1969-02-15

7.  Hodgkin's disease and some solid tumours.

Authors:  A M Jelliffe
Journal:  Proc R Soc Med       Date:  1966-12

8.  Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.

Authors:  R H Earhart; J D Khandekar; D Faraggi; R A Schinella; T E Davis
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

9.  Vinblastine in the treatment of Hodgkin's disease.

Authors:  A M Jelliffe
Journal:  Br J Cancer       Date:  1969-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.